Fuming Qiu
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Immunology top 5%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 27
- HER2/EGFR in Cancer Research 9
- Cancer Cells and Metastasis 6
- Cancer Treatment and Pharmacology 6
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Jian Huang (23 shared papers)Pin Wu (11 shared papers)Meihua Sui (3 shared papers)Dang Wu (7 shared papers)Zhigang Zhang (8 shared papers)Chao Ni (7 shared papers)Jinghong Xu (4 shared papers)Jun Yan (7 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Cancer Letters (4 papers)PLoS ONE (3 papers)Annals of Oncology (2 papers)OncoImmunology (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fuming Qiu
51 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 430
- Immunology 593
- Oncology 626
- Biotechnology 180
- Molecular Biology 774
Countries citing papers authored by Fuming Qiu
This map shows the geographic impact of Fuming Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuming Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuming Qiu more than expected).
Fields of papers citing papers by Fuming Qiu
This network shows the impact of papers produced by Fuming Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuming Qiu. The network helps show where Fuming Qiu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fuming Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 161 | |
| 2 | 2013 | 142 | |
| 3 | 2019 | 131 | |
| 4 | 2020 | 127 | |
| 5 | 2021 | 123 | |
| 6 | 2015 | 117 | |
| 7 | 2014 | 108 | |
| 8 | 2016 | 99 | |
| 9 | 2010 | 96 | |
| 10 | 2017 | 95 | |
| 11 | 2015 | 94 | |
| 12 | 2015 | 81 | |
| 13 | 2015 | 75 | |
| 14 | 2006 | 71 | |
| 15 | 2020 | 59 | |
| 16 | 2013 | 48 | |
| 17 | 2013 | 41 | |
| 18 | 2015 | 41 | |
| 19 | 2019 | 34 | |
| 20 | 2018 | 33 |
About Fuming Qiu
Fuming Qiu is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 58 papers that have together received 2.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Immune Cell Function and Interaction (7 papers), Cancer Cells and Metastasis (6 papers), Immunotherapy and Immune Responses (6 papers), Cancer Treatment and Pharmacology (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Advanced Breast Cancer Therapies (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Cancer Research (430 citations), Immunology (593 citations), Oncology (626 citations), Biotechnology (180 citations) and Molecular Biology (774 citations). Fuming Qiu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jian Huang, Pin Wu, Meihua Sui, Dang Wu, Zhigang Zhang, Chao Ni, Jinghong Xu, Jun Yan, Xianguo Wu and Zhigang Chen. Their work appears in journals such as Journal of Clinical Oncology, Cancer Letters, PLoS ONE, Annals of Oncology and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.